MedPath

Vascular Access for Minimally-invasive Leadless Pacemaker Implantation Through the Right Jugular routE

Conditions
Same-day Discharge
Leadless Pacemaker
Registration Number
NCT06455566
Lead Sponsor
University Hospital, Caen
Brief Summary

Leadless pacemakers (LP) are associated with a lower risk of revision compared with transvenous pacemakers. However, LPs implantation is associated with a 0.6% risk of complication at the femoral vein puncture site (e.g. arteriovenous fistula, haemorrhage, pseudoaneurysm, etc.). As a consequence, the need for prolonged in-hospital monitoring after LP implantation though the right femoral (RF)vein is a barrier to same-day discharge. Recently, right internal jugular (RIJ) vein access has emerged an alternative to right RF vein access for LP implantation (with a regulatory approval for MEDTRONIC Micra LP).

The aims of this registry are the following :

* evaluate the feasibility of RIJ access for LP implantation;

* confirm the acute and chronic safety of RIJ access for LP implantation;

* compare RIJ to RF (historical cohort) vein access regarding procedural characteristics and outcomes;

* evaluate the feasibility of same-day discharge avec LP implantation through the RIJ vein.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Indication of pacemaker implantation
  • Eligible to leadless pacemaker
Exclusion Criteria
  • Contraindication to right internal jugular vein access
  • Age < 18 year-old
  • Patient already included in a clinical study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of effective of jugular access[0 - 1 Month]

Feasibility of jugular access for leadless pacemaker implantation, defined as the percentage of patients with a successful leadless pacemaker implantation through the jugular vein.

Incidence of major cardiovascular event[0 - 12 Month]

Incidence of major complications related to the implantation of a leadless through the jugular vein:

* pericardial complications (effusion, tamponade, pericardiocentesis)

* jugular venous complications (bleeding, hematoma, arteriovenous fistula, vascular surgery)

* carotid artery complications (bleeding, transient ischemic attack or stroke, vascular surgery)

* pacemaker malfunction

* infection

* cardiac rhythm complications (atrioventricular block, ventricular fibrillation ou tachycardia, cardiac arrest)

* air embolism

Rate of effective same-day discharge[0 - 1 Month]

Feasibility of same-day discharge after implantation of a leadless pacemaker through the jugular vein, defined as a successful same-day discharge with no readmission during the first postoperative month.

Secondary Outcome Measures
NameTimeMethod
Description of procedural characteristicsDuring implantation procedure

Procedural characteristics of leadless pacemaker implantation through the jugular vein (duration, position, number of attempts, ...).

Trial Locations

Locations (13)

Angers University Hospital

🇫🇷

Angers, France

Caen University Hospital

🇫🇷

Caen, France

Grenoble University Hospital

🇫🇷

Grenoble, France

Lille University Hospital

🇫🇷

Lille, France

Lyon University Hospital

🇫🇷

Lyon, France

Metz-Thionville Regional Hospital

🇫🇷

Metz, France

Le Millénaire Private Hospital

🇫🇷

Montpellier, France

Les Franciscaines Private Hospital

🇫🇷

Nimes, France

Rennes University Hospital

🇫🇷

Rennes, France

La Réunion University Hospital

🇫🇷

Saint Pierre De La Réunion, France

Scroll for more (3 remaining)
Angers University Hospital
🇫🇷Angers, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.